BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30719104)

  • 1. Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.
    Chen Y; Liu L; Guo Z; Wang Y; Yang Y; Liu X
    Oncol Lett; 2019 Feb; 17(2):2047-2056. PubMed ID: 30719104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma.
    Wang F; Qi X; Li Z; Jin S; Xie Y; Zhong H
    Cancer Manag Res; 2019; 11():3813-3828. PubMed ID: 31118799
    [No Abstract]   [Full Text] [Related]  

  • 3. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
    Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CADM1/TSLC1 inhibits melanoma cell line A375 invasion through the suppression of matrix metalloproteinases.
    You Y; Zhang J; Li Y; Li Y; Shi G; Ma L; Wei H
    Mol Med Rep; 2014 Nov; 10(5):2621-6. PubMed ID: 25215547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer.
    Saito M; Goto A; Abe N; Saito K; Maeda D; Ohtake T; Murakami Y; Takenoshita S
    Oncol Lett; 2018 Feb; 15(2):2401-2406. PubMed ID: 29434950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.
    Yang Z; Wang R; Zhang T; Dong X
    Int J Clin Exp Pathol; 2015; 8(8):8869-80. PubMed ID: 26464628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and Clinical Characteristics of Cell Adhesion Molecule CADM1 in Cancer.
    Li H; Gao J; Zhang S
    Front Cell Dev Biol; 2021; 9():714298. PubMed ID: 34395444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
    Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease.
    Chen K; Wang G; Peng L; Liu S; Fu X; Zhou Y; Yu H; Li A; Li J; Zhang S; Bai Y; Zhang Y
    Int J Cancer; 2011 Jan; 128(2):266-73. PubMed ID: 20340131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma.
    Zhang W; Xie HY; Ding SM; Xing CY; Chen A; Lai MC; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):289-96. PubMed ID: 27298105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits bladder cancer progression via regulation of β-catenin expression.
    Shi J; Wang Y; Jia Z; Gao Y; Zhao C; Yao Y
    Tumour Biol; 2017 Jul; 39(7):1010428317702548. PubMed ID: 28705118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
    Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
    Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
    Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
    Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of tumor suppressor genes induced by human papillomavirus in cervical cancer.
    Yanatatsaneejit P; Chalertpet K; Sukbhattee J; Nuchcharoen I; Phumcharoen P; Mutirangura A
    Oncol Lett; 2020 Jul; 20(1):955-961. PubMed ID: 32566025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
    Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
    Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
    J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
    Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
    Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.